TFS CAPITAL LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 120 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$86,000
-32.8%
31,418
-18.5%
0.03%
-19.0%
Q1 2017$128,000
-43.4%
38,559
-59.4%
0.04%
-30.0%
Q4 2016$226,000
-56.3%
94,869
-59.1%
0.06%
-36.8%
Q2 2016$517,000
-71.3%
231,756
-73.2%
0.10%
-63.3%
Q1 2016$1,800,000
-52.5%
865,197
-30.9%
0.26%
-36.5%
Q4 2015$3,791,000
+0.3%
1,251,289
-18.2%
0.41%
+12.1%
Q3 2015$3,778,000
-32.6%
1,529,481
-12.5%
0.36%
-33.6%
Q2 2015$5,609,000
+377.4%
1,747,400
+430.9%
0.55%
+376.5%
Q1 2015$1,175,000
+152.1%
329,146
+60.4%
0.12%
+161.4%
Q4 2014$466,000
-75.2%
205,169
-78.8%
0.04%
-73.0%
Q3 2014$1,879,000
-30.0%
968,599
+31.0%
0.16%
-22.7%
Q2 2014$2,684,000
+89.3%
739,492
+102.3%
0.21%
+124.5%
Q1 2014$1,418,000
+3.1%
365,562
-24.2%
0.09%
+44.6%
Q4 2013$1,375,000
-34.0%
482,557
-17.0%
0.06%
-31.6%
Q3 2013$2,082,000
+31.6%
581,485
+22.7%
0.10%
+41.8%
Q2 2013$1,582,000473,7370.07%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders